ATE439125T1 - Fenofibrate tablett und verfahren zur herstellung - Google Patents

Fenofibrate tablett und verfahren zur herstellung

Info

Publication number
ATE439125T1
ATE439125T1 AT04715360T AT04715360T ATE439125T1 AT E439125 T1 ATE439125 T1 AT E439125T1 AT 04715360 T AT04715360 T AT 04715360T AT 04715360 T AT04715360 T AT 04715360T AT E439125 T1 ATE439125 T1 AT E439125T1
Authority
AT
Austria
Prior art keywords
fenofibrate
tray
producing
active ingredient
granulation
Prior art date
Application number
AT04715360T
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Sarl Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarl Galenix Innovations filed Critical Sarl Galenix Innovations
Application granted granted Critical
Publication of ATE439125T1 publication Critical patent/ATE439125T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04715360T 2003-02-28 2004-02-27 Fenofibrate tablett und verfahren zur herstellung ATE439125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302520A FR2851734B1 (fr) 2003-02-28 2003-02-28 Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
PCT/FR2004/050090 WO2004078108A2 (fr) 2003-02-28 2004-02-27 Comprime de fenofibrate et procede de fabrication

Publications (1)

Publication Number Publication Date
ATE439125T1 true ATE439125T1 (de) 2009-08-15

Family

ID=32843093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715360T ATE439125T1 (de) 2003-02-28 2004-02-27 Fenofibrate tablett und verfahren zur herstellung

Country Status (20)

Country Link
US (1) US20060177499A1 (de)
EP (1) EP1601346B1 (de)
JP (1) JP2006520770A (de)
CN (1) CN100479808C (de)
AT (1) ATE439125T1 (de)
AU (1) AU2004216869B2 (de)
BR (1) BRPI0407850A (de)
CA (1) CA2517429C (de)
DE (1) DE602004022515D1 (de)
FR (1) FR2851734B1 (de)
IL (1) IL170507A (de)
MA (1) MA27662A1 (de)
MX (1) MXPA05009113A (de)
NO (1) NO20054417L (de)
NZ (1) NZ542039A (de)
PL (1) PL378106A1 (de)
RU (1) RU2362547C2 (de)
TN (1) TNSN05203A1 (de)
WO (1) WO2004078108A2 (de)
ZA (1) ZA200506992B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273849A (ja) * 2005-03-02 2006-10-12 Aska Pharmaceutical Co Ltd フェノフィブラート含有組成物
CN101460150B (zh) * 2006-03-31 2014-02-12 鲁比康研究私人有限公司 用于口腔崩解片剂的可直接压片复合物
CN100577157C (zh) * 2006-07-12 2010-01-06 姚俊华 含有降血脂成分的分散片及其制备方法
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
CN102675748A (zh) * 2012-05-22 2012-09-19 苏州新区华士达工程塑胶有限公司 一种耐候聚丙烯的配方
CN110325177A (zh) * 2017-02-20 2019-10-11 帝斯曼知识产权资产管理有限公司 生产包衣颗粒的方法
KR102271734B1 (ko) * 2020-10-21 2021-07-01 한국프라임제약주식회사 건식과립공정용 멀티비타민 약제학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DE4414538A1 (de) * 1994-04-26 1995-11-02 Klinge Co Chem Pharm Fab Präparate zur Therapie der kombinierten Hyperlipidämie mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem Fibrat
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6180138B1 (en) * 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
EP1276465B1 (de) * 2000-04-20 2014-03-12 Jagotec AG Verbessertes verfahren zur herstellung wasserunlöslicher arzneistoffpartikel
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
NZ527408A (en) * 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
EP1364646A4 (de) * 2001-03-01 2005-08-03 Grelan Pharmaceutical Co Fenofibrat enthaltende zusammensetzung

Also Published As

Publication number Publication date
JP2006520770A (ja) 2006-09-14
CA2517429A1 (fr) 2004-09-16
DE602004022515D1 (de) 2009-09-24
AU2004216869A1 (en) 2004-09-16
FR2851734A1 (fr) 2004-09-03
MA27662A1 (fr) 2005-12-01
RU2362547C2 (ru) 2009-07-27
MXPA05009113A (es) 2006-05-31
RU2005130155A (ru) 2006-06-10
CN1780606A (zh) 2006-05-31
AU2004216869B2 (en) 2009-05-14
WO2004078108A3 (fr) 2004-12-09
CN100479808C (zh) 2009-04-22
NZ542039A (en) 2008-08-29
WO2004078108A2 (fr) 2004-09-16
IL170507A (en) 2011-11-30
BRPI0407850A (pt) 2006-03-14
US20060177499A1 (en) 2006-08-10
TNSN05203A1 (fr) 2007-06-11
ZA200506992B (en) 2007-04-25
EP1601346A2 (de) 2005-12-07
CA2517429C (fr) 2012-04-17
FR2851734B1 (fr) 2006-06-09
EP1601346B1 (de) 2009-08-12
NO20054417L (no) 2005-09-23
PL378106A1 (pl) 2006-03-06

Similar Documents

Publication Publication Date Title
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
CY1118179T1 (el) Φαρμακευτικη συνθεση
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
ATE361058T1 (de) Tablette und verfahren zur herstellung derselben
ATE551100T1 (de) Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
EP1824442A4 (de) Pharmazeutische und therapeutische zusammensetzungen aus der garcinia-mangostana-l-pflanze
EP1513825A4 (de) Antituberkulöses arzneimittel: zusammensetzungen und verfahren
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
ATE419837T1 (de) Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen
GT200400220A (es) Productos para las axilas con componente superabsorbente.
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
ATE439125T1 (de) Fenofibrate tablett und verfahren zur herstellung
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
NO20076120L (no) Stabile nanopartikkelformuleringer
ATE477802T1 (de) Tablettenförmige retardzubereitung enthaltend cinnarizin und dimenhydrinat gegen schwindel
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties